ovulation rate
Recently Published Documents


TOTAL DOCUMENTS

921
(FIVE YEARS 68)

H-INDEX

50
(FIVE YEARS 2)

Author(s):  
Tahreer M. Al-Thuwaini ◽  
Thamer R. S. Aljubouri ◽  
Mohammed Baqur S. Al-Shuhaib ◽  
Ismael K. Ajam ◽  
Saeid Ansari Mahyari

Animals ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 3200
Author(s):  
Imane Hadjadj ◽  
Anna-Katharina Hankele ◽  
Eva Armero ◽  
María-José Argente ◽  
María de la Luz García

The aim of this study was to analyse the fatty acid (FA) profile of blood plasma at mating and 72 hpm by gas chromatography. Moreover, the correlation between FA and ovulation rate, normal embryos and compacted morulae was estimated. Palmitic, linoleic, oleic and stearic were the highest FA concentrations at mating and 72 hpm. Most long chain saturated and PUFA were higher at 72 hpm than at mating, while MUFA were higher at mating. SFA, MUFA and PUFA were high and positively correlated. Correlation was 0.643 between MUFA at mating and ovulation rate, and 0.781 between MUFA and normal embryos, respectively. Compacted morulae were slightly correlated with SFA at mating (0.465). In conclusion, the FA profile of plasma varies depending on the reproductive cycle of the rabbit female, adapting to energetic requirements at mating and early gestation. Moreover, positive correlations are found between fatty acids and ovulation rate and embryo development and quality.


2021 ◽  
Author(s):  
◽  
Elisabeth Sheinach Feary

<p>Fecundity is a term that refers to the number of offspring produced per female. It combines fertility (i.e. ability to produce offspring) and prolificacy (i.e. number of offspring). Ovulation rate i.e. the number of mature eggs released from the ovaries during one reproductive cycle in sheep, as with other mammals, is controlled by an exchange of hormonal signals between the pituitary gland and the ovary. Genetic mutations affecting ovulation are commonly referred to as the fecundity genes (Fec). The most obvious outcome is the number of offspring produced. There is already evidence of a number of major genes affecting the ovulation rate in sheep, specifically the Booroola, Inverdale, Hanna and more recently the Woodlands gene. The sheep carrying the Woodlands gene arose because the mutation was first recognised on a farm in Woodlands, Southland, New Zealand. Woodlands have a novel, X-linked maternally-imprinted, fecundity trait referred to as FecX2w, where Fec = fecundity, X = X chromosome, 2= 2nd mutation identified on X and W= Woodlands. The studies in this thesis investigated ovarian follicular development in both 4-week old Woodland carrier (W+) and non-carrier (++) lambs and adult ewes and evaluated some aspects of the endocrine interactions between the ovary and pituitary gland. The purpose was to identify potential physiological effects of the FecX2w gene on ovarian function. A confounding issue during these studies was the discovery that a large ovary phenotype (LOP) which was present in many of the W+ but not ++ lambs at 4 weeks of age was in fact a coincidence and not linked to the FecX2w mutation. The key findings from the studies of lambs and/or ewes that were carriers (W+) or non-carriers (++) of the FecX2w gene were: 1. No genotype differences were present either in the numbers of primordial (i.e. Type 1/1a follicles) or developing preantral (i.e. Types 2-4 follicles); 2. Significant genotype differences were present in the numbers of small antral (Type 5) follicles (W+>++; p<0.05); 3. An earlier onset of antral follicular development in W+ vs. ++ ewes with irregularities in morphology between the basement membrane and stroma in the former; 4. No genotype differences in the onset of gene expression during follicular development or in the cell-types expressing GDF9, BMP15, alpha inhibin, beta A inhibin and beta B inhibin, FSHR, ER alpha, or ER beta; 5. No genotype differences in the levels of GDF9 or BMP15 gene expression in oocytes throughout follicular growth; 6. No genotype difference in the diameters that follicles reached in W+ vs. ++ ewes; 7. Some lambs at 4-weeks of age had unusually large ovaries with an exceptional level of antral follicular development that is reminiscent of a polycystic ovarian condition. The underlying cause of this condition is unknown. In conclusion, the physiological characteristics of ovarian follicular development in ewes with the FecX2w gene is different from that in ewes with the Booroola, Inverdale, Hanna or other recently identified mutations.</p>


2021 ◽  
Author(s):  
◽  
Elisabeth Sheinach Feary

<p>Fecundity is a term that refers to the number of offspring produced per female. It combines fertility (i.e. ability to produce offspring) and prolificacy (i.e. number of offspring). Ovulation rate i.e. the number of mature eggs released from the ovaries during one reproductive cycle in sheep, as with other mammals, is controlled by an exchange of hormonal signals between the pituitary gland and the ovary. Genetic mutations affecting ovulation are commonly referred to as the fecundity genes (Fec). The most obvious outcome is the number of offspring produced. There is already evidence of a number of major genes affecting the ovulation rate in sheep, specifically the Booroola, Inverdale, Hanna and more recently the Woodlands gene. The sheep carrying the Woodlands gene arose because the mutation was first recognised on a farm in Woodlands, Southland, New Zealand. Woodlands have a novel, X-linked maternally-imprinted, fecundity trait referred to as FecX2w, where Fec = fecundity, X = X chromosome, 2= 2nd mutation identified on X and W= Woodlands. The studies in this thesis investigated ovarian follicular development in both 4-week old Woodland carrier (W+) and non-carrier (++) lambs and adult ewes and evaluated some aspects of the endocrine interactions between the ovary and pituitary gland. The purpose was to identify potential physiological effects of the FecX2w gene on ovarian function. A confounding issue during these studies was the discovery that a large ovary phenotype (LOP) which was present in many of the W+ but not ++ lambs at 4 weeks of age was in fact a coincidence and not linked to the FecX2w mutation. The key findings from the studies of lambs and/or ewes that were carriers (W+) or non-carriers (++) of the FecX2w gene were: 1. No genotype differences were present either in the numbers of primordial (i.e. Type 1/1a follicles) or developing preantral (i.e. Types 2-4 follicles); 2. Significant genotype differences were present in the numbers of small antral (Type 5) follicles (W+>++; p<0.05); 3. An earlier onset of antral follicular development in W+ vs. ++ ewes with irregularities in morphology between the basement membrane and stroma in the former; 4. No genotype differences in the onset of gene expression during follicular development or in the cell-types expressing GDF9, BMP15, alpha inhibin, beta A inhibin and beta B inhibin, FSHR, ER alpha, or ER beta; 5. No genotype differences in the levels of GDF9 or BMP15 gene expression in oocytes throughout follicular growth; 6. No genotype difference in the diameters that follicles reached in W+ vs. ++ ewes; 7. Some lambs at 4-weeks of age had unusually large ovaries with an exceptional level of antral follicular development that is reminiscent of a polycystic ovarian condition. The underlying cause of this condition is unknown. In conclusion, the physiological characteristics of ovarian follicular development in ewes with the FecX2w gene is different from that in ewes with the Booroola, Inverdale, Hanna or other recently identified mutations.</p>


Author(s):  
Madeley Gladys Hilasaca Mamani ◽  
◽  
Jesús Martín Urviola Sánchez ◽  
Francisco Halley Rodríguez Huanca ◽  
Víctor Raúl Leyva Vallejos ◽  
...  

An experiment was carried out at the Experimental Center La Raya-Universidad Nacional del Altiplano Puno, to determine the effect of copulation duration on ovulation and pregnancy in alpacas. 47 adult females were used (postpartum time ≥ 20 days and presence of a follicle ≥ 7 mm) distributed in three groups, according to copulation time: 20, 35 and 50 min, for G1 (n = 15), G2 (n = 16) and G3 (n = 16), respectively. For the mating, 6 reproducers of proven fertility were used, interrupting the copulation at the established time. Ovulation and pregnancy rates were evaluated on days 7 and 30 post service respectively (by ultrasound and receptivity of the female), the data were analyzed using X2 and simple correspondence. Both the ovulation rate (G1: 73.33%, G2: 81.25% and G3: 81.25%); and pregnancy (G1: 53.33%, G2: 81.25% and G3: 75%) were not different (P> 0.05). Pregnancy rates between G1 and G2 tended to be different (P <0.10), consistent with the simple correspondence analysis. Despite there being no differences in ovulation and pregnancy rates, there was a higher percentage trend in G2 and G3, suggesting that the longer duration of mating would have some positive effect on them, according to the simple correspondence analysis, and the trend of low significance (P <0.10) in favor of pregnancy in G2 compared to G1. In conclusion, there were no significant differences in the effect of copulation duration on ovulation; however, there was a 90% trend for the difference between mating duration of 35 minutes versus 20 minutes (in pregnancy).


2021 ◽  
Vol 12 ◽  
Author(s):  
Jing-Yan Zhu ◽  
Jian Liu ◽  
Xiao-Jing Cao ◽  
Xiao-Yun Wang

Objective: To compare the efficacy of various listed Chinese patent medicines combined with letrozole in the treatment of ovulation disorders using network meta-analysis (NMA). Methods: We conducted a systematic literature search in PubMed, Cochrane Central Register of Controlled Trials, Embase, Chinese Biomedical Literature, China National Knowledge Infrastructure, Wanfang, and VIP Information databases up to June 2020. Randomized controlled trials reporting Chinese patent medicine combined with letrozole for ovulation disorders were included. The Stata 13 and WinBUGS1.43 software were used for data analysis. Results: A total of 24 randomized controlled trials were included, involving 2,318 patients. The results showed that when compared with patients using only letrozole, the ovulation rate was higher in patients using letrozole combined with Kuntai capsules, Fuke Zaizao capsules, Fufang Xuanju capsules, or Dingkun Dan, and Fufan Xuanju capsules showed the greatest improvement; the pregnancy rate was higher in patients using letrozole combined with Kuntai capsules, Fuke Zaizao capsules, or Dingkun Dan; and the endometrial thickness on the day of follicular maturity was greater in patients using letrozole combined with Kuntai capsules, Fuke Zaizao capsules, Fufang Xuanju capsules, Bailing capsules, or Dingkun Dan. In terms of the sequencing of NMA results, Fufang Xuanju capsules combined with letrozole gave the best results in improving the ovulation rate and increasing the endometrial thickness, while Dingkun Dan combined with letrozole achieved the best results for improving the pregnancy rate. Conclusion: Letrozole combined with Chinese patent medicine is more effective than letrozole alone in the treatment of ovulation disorders. Fufang Xuanju capsules is good at improving the ovulation rate and increasing the endometrial thickness. Dingkun Dan is good at improving the pregnancy rate. The appropriate choice of treatment should be made according to the actual clinical situation. This study is registered with the International Prospective Register of Systematic Reviews (CRD42020200603).


Author(s):  
MOHAMMED ABDALLA ◽  
Najeeb Shah ◽  
Harshal Deshmukh ◽  
Amirhossein Sahebkar ◽  
Linda Östlundh ◽  
...  

Background: Polycystic ovary syndrome (PCOS) is an endocrine condition associated with sub-fertility, infertility and poor reproductive outcomes. Objectives: To review the effectiveness of different pharmacological interventions on fertility outcomes in women with PCOS. Search Strategy: We searched PubMed, MEDLINE, Scopus, Embase, Cochrane Library, Web of Science in April 2020 and updated the search in PubMed March 2021. Selection Criteria: Two independent reviewers selected studies, and only randomised controlled trials (RCTs) were included. Data Collection and Analysis: Thirty-four RCTs that met the eligibility criteria were used to calculate odds ratios (OR) and the 95% confidence interval (95% CI) using the random effect model. Main Results: There was a significant increase in pregnancy rate with follicular stimulating hormone (FSH) vs clomiphene citrate (CC)+ metformin (Odd Ratio(OR):4.08; 95%CI:1.12-14.83,I²=79%), Letrozole vs CC (OR: 1.58; 95%CI: 1.34-1.86, I²= 0%), metformin vs placebo(OR: 3.00; 95%CI: 1.95-4.59, I²= 0%) and with CC+ metformin vs CC (OR: 1.48; 95%CI: 1.02-2.16, I²= 39%). There were significant increases in ovulation rate with CC+ metformin vs FSH (OR: 0.09; 95%CI: 0.02-0.37, I² = 75%), CC+ metformin vs CC (OR: 2.04; 95%CI: 1.35-3.08, I² = 63%) and with Letrozole vs CC (OR: 1.60; 95%CI: 1.02-2.52, I²= 88%). A significant increase in live birth with Letrozole vs CC (OR: 1.63; 95%CI: 1.21-2.21, I² = 0%) was observed. Conclusions: CC, letrozole alone or either added to metformin, were associated with a significant increase in the pregnancy rate, ovulation rate, and live birth rate in women with PCOS. Funding: No fund for the review.


2021 ◽  
Vol 20 (1) ◽  
pp. 49-59
Author(s):  
Rujira Chumchai ◽  
◽  
Thanaporn Ratsiri ◽  
Ruthaiporn Ratchamak ◽  
Wuttigrai Boonkum ◽  
...  

This study was designed (1) to examine the relationship between ovary sides/sizes after superstimulation treatment and ovulatory responses in terms of large follicles, corpora lutea (CLs) numbers, and ovulation rate; and (2) to evaluate the coefficient of determination (R2) as a tool to predict the subsequent superovulatory responses by ovary sizes after superstimulation treatment in the Thai-Holstein crossbreed dairy cows. Data included 33 records from 12 superovulated Thai Holstein crossbreds. Cows were estrus synchronized on day 0 and superstimulated with 400 mg of FSH with decreasing doses twice daily for 4 days. After superovulatory treatment (day 9), the sizes of ovaries were measured and divided into 3 groups by quarters according to the ovarian sizes. Group A (< 816 mm2) ovaries were 25% smaller and group C (> 1449 mm2) ovaries were 25% larger than group B ovaries (816–1449 mm2). On day 9 and 16, there were no significant differences in the average ovary area (p > 0.05). The numbers of large follicles and CLs of group B and C were greater than those of group A (p < 0.05). The ovulation rate did not differ among groups (p > 0.05). The moderate R2 score between ovary size after superovulatory treatment and the numbers of dominant follicles and CLs were calculated (R2 = 0.445 and 0.370, p <0.05) while the beta coefficient (b-value) was positive for both observation parameters. In conclusion, the numbers of large follicles and CLs related to the size of ovaries after superovulation treatment. The moderate R2 score obtained in this study could be indicative of the limited possibility for using ovary size after superovulatory treatment for predicting superovulatory responses


Animals ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 2591
Author(s):  
Rosa Peiró ◽  
Celia Quirino ◽  
Agustín Blasco ◽  
María Antonia Santacreu

The aim of this work was to estimate correlated responses in growth traits and their variabilities in an experiment of selection for ovulation rate during 10 generations in rabbits. Individual weight at 28 days old (IW28, kg) and at 63 days old (IW63, kg) was analyzed, as well as individual growth rate (IGR = IW63 − IW28, kg). The variability of each growth trait was calculated as the absolute value of the difference between the individual value and the mean value of their litter. Data were analyzed using Bayesian methodology. The estimated heritabilities of IW28, IW63 and IGR were low, whereas negligible heritabilities were obtained for growth variability traits. The common litter effect was high for all growth traits, around 30% of the phenotypic variance, whereas low maternal effect for all growth traits was obtained. Low genetic correlations between ovulation rate and growth traits were found, and also between ovulation rate and the variability of growth traits. Therefore, genetic trends methods did not show correlated responses in growth traits. A similar result was also obtained using a cryopreserved control population.


SPERMOVA ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 60-66
Author(s):  
Daniel Scandolo ◽  
◽  
Alejandra Cuatrin ◽  
Virginia Mazzuca ◽  
Mariano Finello ◽  
...  

The objective was to determine the size of the dominant ovulatory follicle, the ovulation time and the conception rate of cows in anestrus treated with serum equine chorionic gonadotropin (eCG), recombinant chorionic gonadotropin and untreated controls. 57 anestrus primiparous Brangus cows were used with 70 ± 26 days of calving and a body condition of 2.50 ± 0.15. They were synchronized with a FTAI protocol based on estrogen and progesterone devices (DI). Upon removal of DI, 3 groups were made according to the type of eCG applied: serum eCG received 400 IU im of equine Chorionic Gonadotropin, recombinant eCG received 140 IU of recombinant Equine Chorionic Gonadotrophin and Control did without treatment. Follicular size and time of ovulation (normal or abnormal) was determined at DI removal, during FTAI and 7 days later. An ANOVA was performed to determine the effect of the treatment on ovarian dynamics and a chi-square test and correspondence analysis to establish associations. In normal ovulation cows at the FTAI, 94.4% of the serum eCG, 55.5% of the recombinant eCG and 71.4% of the Control cows presented a dominant ovulatory follicle (DOF), which in those treated with serum eCG, it was 1.4 mm greater in relation to the Control (P = 0.0073). The ovulation rate, in normal and abnormal ovulation cows, was 94.4% for serum eCG, and for recombinant eCG and 66.6% for Controls. A significant association was detected between ovulation time and the treated groups (P = 0.0042). Normal ovulation was 38.9% higher in cows with serum eCG in relation to those treated with recombinant eCG and 50.8% in comparison with Control. A significant relationship was observed between the conception rate and the groups treated with the different Gonadotropins (P = 0.0574), being 66.7% in serum eCG, 50% in recombinant eCG and 28.6% in the Control. The use of eCG, either serum or recombinant, in anestrus primiparous cows, stimulates the development of DOF at FTAI, increases ovulation rate and improves conception in relation to untreated cows.


Sign in / Sign up

Export Citation Format

Share Document